Kim Robien PhD, RD » Faculty

Biostatistics EnHS EpiCH HPM

Kim Robien PhD, RD

Associate Professor

School of Public HealthDivision of Epidemiology & Community Health

Address Div. Epidemiology & Community Health 1300 S. 2nd Street Suite 300 Minneapolis MN 55454
Photo of  Kim Robien PhD, RD

Biography:

Kim Robien received her Ph.D. in nutritional sciences at the University of Washington-Seattle, and completed a postdoctoral fellowship in molecular epidemiology at the Fred Hutchinson Cancer Research Center. Her research program focuses on nutrition in cancer prevention and survivorship, with a special focus on folate and vitamin D. She is also interested in environmental nutrition and sustainable food systems, and the extent to which exposure to pesticides, synthetic fertilizers and other chemicals through food and water may contribute to risk of cancer and other chronic diseases.

  • PhD, Nutritional Sciences, School of Public Health, University of Washington, Seattle, WA
  • MS, Dietetics, Massachusetts General Hospital Institute of Health Professions, Boston, MA
  • BS, Dietetics, University of Wisconsin, Madison, WI

Professional Experience:

  • 2005 – 2011 Assistant Professor, Epidemiology and Community Health, School of Public Health, University of Minnesota<
  • 2003 – 2005 Postdoctoral Fellow, Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA
  • 2001 – 2003 Predoctoral Research Assistant, Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA
  • 1996 – 2001 Dietitian, Clinical Nutrition Program Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance Seattle, WA
  • 1995 – 1996 Clinical Teaching Assistant, Interdisciplinary Graduate Program in Nutritional Sciences, University of Washington, Seattle, WA
  • 1992 – 1995 Clinical Dietitian, Massachusetts General Hospital, Boston, MA
  • 1991 – 1992 Assistant Research Dietitian, Mallinckrodt General Clinical Research Center, Massachusetts General Hospital, Boston, MA
  • 1989 – 1991 Clinical Dietitian, St. Francis Hospital of Evanston, Evanston, IL

Honors:

  • George Santos Award for best clinical science article by a new investigator (American Society for Blood and Marrow Transplantation), 2006
  • Connie San Andres-Robles Oncology Nutrition Dietetic Practice Group Distinguished Service Award, 2006
  • American Association for Cancer Research (AACR)-GlaxoSmithKline Outstanding Clinical Scholar Award, 2004
  • Fellow of the American Dietetic Association, 2001
  • President’s Award, Washington State Dietetic Association, 2000
  • Recognized Young Dietitian of the Year, Washington State Dietetic Association, 2000
  • Louise Hatch Award, Massachusetts General Hospital Institute of Health Professions, 1992

Research Interests:

Dr. Robien’s research focuses on nutrition in cancer prevention and survivorship. Vitamin D and folate have been the focus of her research to date. She is also interested in environmental nutrition and sustainable food systems, and the extent to which exposure to pesticides, synthetic fertilizers and other chemicals through food and water may contribute to risk of cancer and other chronic diseases.

Member: Masonic Cancer Center, University of Minnesota (http://www.cancer.umn.edu/)

Resident Fellow, Institute on the Environment, Univesity of Minnesota (http://environment.umn.edu/)

Selected Publications:

  • Mursu J, Robien K, Harnack L, Park K, Jacobs DR.  The use of dietary supplements and total and cardiovascular mortality: Iowa Women’s Health Study.  Archives of Internal Medicine 2011; 171(18):1625-1633. PMID: 21987192.
  • Oppeneer SJ, Robien K.  Tea consumption and epithelial ovarian cancer risk: a systematic review of observational studies.  Nutrition and Cancer  2011;63(6):817-26.PMID: 21800977.
  • Mason C, Xiao L, Imayama I, Duggan CR, Bain C, Foster-Schubert KE, Kong A, Campbell KL, Wang CY, Neuhouser ML, Li L, Jeffery RW, Robien K, Alfano CM, Blackburn GL, McTiernan A.  Effects of weight loss on serum vitamin D in post-menopausal women.  American Journal of Clinical Nutrition 2011;94 95-103.  PMID: 21613554.
  • Inoue-Choi M, Flood AP, Robien K, Anderson KE.  Nutrient, food groups, dietary patterns and risk of pancreatic cancer in postmenopausal women.  Cancer Epidemiol Biomarkers Prev  2011;20 711-714.  PMID: 21278328.
  • Uccella S, Mariani A, Wang AH, Vierkant RA, Robien K, Anderson KE, Cerhan JR.  Dietary and supplemental intake of one-carbon metabolism and the risk of Type I and Type II endometrial cancer: a prospective cohort study.  Annals of Oncology 2011;22(9):2129-36.  PMID: 21324952.
  • Robien K, Strayer LG, Majhail N, Lazovich D, Baker KS, Smith AR, Mulrooney D, Burns LJ.  Vitamin D status among long-term survivors of hematopoietic cell transplantation. Bone Marrow Transplantation 2011; 46: 1472-1479.  PMID: 2124306.
  • Robien K, Demark-Wahnefried W, Rock CL.  Nutrition and the cancer survivor: The need for further research to support development of evidence-based nutrition guidelines.  J Am Diet Assoc  2011, 111:368-375.  PMID: 21338735.
  • Jang S, Prizment A, Haddad T, Robien K, Lazovich D.  Smoking and quality of life among survivors of breast, colorectal and endometrial cancers in a prospective cohort study.  Journal of Cancer Survivorship  2011;5(2):115-22.  PMID: 20812033.
  • Zhang X, Albanes D, Beeson WL, van den Brandt P, Buring JE, Flood A, Freudenheim JL, Giovannuci EL, Goldbohm RA, Jaceldo K, Jacobs E, Krogh V, Larsson SC, Marshall JR, McCullough ML, Miller AB, Robien K, Rohan TE, Schatzkin A, Sieri S, Spiegelman D, Virtamo J, Wolk A, Willett WC, Zhang SM, Smith-Warner SA.  Intakes of coffee, tea, and sugar-sweetened carbonated soft drinks and risk of colon cancer: A pooled analysis of 13 prospective cohort studies.  J Natl Cancer Inst  2010, 102(11):771-783.  PMID: 20112462.
  • Robien K, Bechard L, Elliott L, Fox N, Levin R, Washburn S.  American Dietetic Association: Revised Standards of Practice and Standards of Professional Performance for Registered Dietitians (Generalist, Specialty, and Advanced) in Oncology Nutrition Care.  J Am Diet Assoc  2010; 110(2):310-317.e23.  PMID: 19731348.
  • Lazovich D, Robien K, Cutler GJ, Virnig B, Sweeney C.  Quality of life in a prospective cohort of women with and without cancer.  Cancer  2009;115(S18):4283-4297.  PMID: 19731348.
  • Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Hankinson SE, Horn-Ross PL, Leitzman M, Marshall JR, Mannisto S, McCullough ML, Miller AB, Robien K, Rohan TE, Schatzkin A, Stolzenberg-Solomon RZ, Verhage BAJ, Wolk A, Smith-Warner SA.  Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.  Cancer Epidemiol Biomarkers Prev 2009; 18(3): 765-776.  PMID: 19258474.
  • Robien K, Snyder DC, Kiyomoto D, Elliott L, Frankmann C. Dietary counseling and quality of life. J Support Oncol 2008;6(8):353-4. PMID: 19149319.
  • Inoue M, Robien K, Wang R, van den Berg D, Koh WP, Yu MC. Green tea intake, MTHFR/TYMS genotype, and breast cancer risk: The Singapore Chinese Health Study. Carcinogenesis 2008;29(10):1967-72. PMID: 18669903.
  • Lueth N, Anderson KE, Harnack LJ, Fulkerson JA, Robien K. Coffee and caffeine intake and the risk of ovarian cancer: The Iowa Women’s Health Study. Cancer Causes and Control 2008;19(10):1365-72. PMID: 18704717.
  • Robien K, Ness KK, Klesges LM, Baker KS, Gurney JG. Poor adherence to dietary guidelines among adult survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology 2008;30(11):815-22. PMID: 18989158.
  • Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR, Scrafford CG, Barraj LM, Mink PJ, Robien K. Dietary flavonoid intake and risk of cancer in postmenopausal women: The Iowa Women’s Health Study. Int J Cancer 2008; 123, 664-671. PMID: 18491403
  • Robien K, Cutler GJ, Lazovich D. Vitamin D intake and breast cancer risk in postmenopausal women: The Iowa Women’s Health Study. Cancer Causes and Control 2007; 18(7):775-782. PMID: 17549593
  • Robien K, Bigler J, Yasui Y, Potter JD, Martin P, Storb R, Ulrich CM. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-vs-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. Biology of Blood and Marrow Transplantation 2006; 12(9):973-980. PMID:16920564.
  • Robien K, Schubert MM, Yasui Y, Martin P, Storb R, Potter JD, Ulrich CM. Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-vs-host disease or relapse following hematopoietic transplantation. Bone Marrow Transplantation 2006; 37(7):687-692. PMID:16501595
  • Robien K, Schubert MM, Chay T, Bigler J, Storb R, Yasui Y, Potter JD, Ulrich CM. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation. Bone Marrow Transplantation 2006; 37(8): 799-800. PMID: 16501586
  • Robien K, Boynton A, Ulrich CM. Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics 2005; 6(7): 673-689. PMID: 16207145
  • Robien K. Folate during antifolate chemotherapy: what we know . . . and don’t know. Nutr Clin Pract 2005; 20 (4): 411 – 422. PMID: 16207681
  • Robien K, Curtin K, Ulrich CM, Bigler J, Samowitz W, Caan B, Potter JD, Slattery ML. Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14(5): 1350 – 1352. PMID: 15894702
  • Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B, Potter JD, Radich JP. Methylenetetrahydrofolate reductase genotype affects risk of relapse following hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res 2004; 10(22): 7592-7598. PMID: 15569990
  • Robien K, Schubert MM, Lloid ME, Bruemmer B, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 2004; 22(7): 1268-1275. PMID: 15051775
  • Ulrich CM, Robien K, McLeod H. Cancer pharmacogenetics: polymorphisms, pathways, and beyond. Nat Rev Cancer 2003; 3(12): 912-920. PMID: 14740638
  • Robien K, Ulrich CM. 5,10 – Methylenetetrahydrofolate reductase gene variants and leukemia: a HuGE minireview. Am J Epidemiol 2003; 157 (7): 571 – 582. PMID: 12672676
  • Ulrich CM, Robien K, Sparks R. Pharmacogenetics and folate metabolism – a promising direction. Pharmacogenomics 2002; 3(3): 299 – 314. PMID: 12052139